{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:07:20Z","timestamp":1792782440782,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Erzincan Binali Y\u0131ld\u0131r\u0131m University Scientific Research Projects Coordination Commission","award":["TSA-2021-797"],"award-info":[{"award-number":["TSA-2021-797"]}],"id":[{"id":"https:\/\/ror.org\/02h1e8605","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"DOI":"10.1007\/s00044-026-03624-4","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:23:13Z","timestamp":1790666593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design and biological evaluation of sulfonamide\u2013chalcone hybrids with in vitro tumor-selective cytotoxicity against oral squamous cell carcinoma: SAR, QSAR, and in silico ADME studies"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6786-2500","authenticated-orcid":false,"given":"Gulsen","family":"Ozli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Fatih","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cavit","family":"Kazaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Kurosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Uesawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Inden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6164-9602","authenticated-orcid":false,"given":"Halise Inci","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"3624_CR1","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/CNCR.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127:3029\u201330. https:\/\/doi.org\/10.1002\/CNCR.33587.","journal-title":"Cancer"},{"key":"3624_CR2","doi-asserted-by":"publisher","first-page":"14213","DOI":"10.1002\/JCB.28782","volume":"120","author":"S Hussain","year":"2019","unstructured":"Hussain S, Singh A, Nazir SU, Tulsyan S, Khan A, Kumar R, et al. Cancer drug resistance: A fleet to conquer. J Cell Biochem. 2019;120:14213\u201325. https:\/\/doi.org\/10.1002\/JCB.28782.","journal-title":"J Cell Biochem"},{"key":"3624_CR3","doi-asserted-by":"publisher","first-page":"2000273","DOI":"10.1002\/ardp.202000273","volume":"354","author":"B Kaya \u00c7avu\u015fo\u011flu","year":"2021","unstructured":"Kaya \u00c7avu\u015fo\u011flu B, Sa\u011fl\u0131k BN, Acar \u00c7evik U, Osmaniye D, Levent S, \u00d6zkay Y, et al. Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX-2 inhibitors. Arch Pharm (Weinheim). 2021;354:2000273. https:\/\/doi.org\/10.1002\/ardp.202000273.","journal-title":"Arch Pharm (Weinheim)"},{"key":"3624_CR4","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1002\/ardp.70001","volume":"358","author":"X Duan","year":"2025","unstructured":"Duan X, Ma X, Chen M, Zhang T, Sun X, Wei M, et al. Design, Synthesis, Biological Evaluation, and In Silico Study of Aspirin\u2013Sulfonamide Hybrids as Potential Anticancer Agents. Arch Pharm (Weinheim). 2025;358:e70001. https:\/\/doi.org\/10.1002\/ardp.70001.","journal-title":"Arch Pharm (Weinheim)"},{"key":"3624_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/J.BIOORG.2018.06.009","volume":"80","author":"X Zhang","year":"2018","unstructured":"Zhang X, Rakesh KP, Bukhari SNA, Balakrishna M, Manukumar HM, Qin HL. Multi-targetable chalcone analogs to treat deadly Alzheimer\u2019s disease: Current view and upcoming advice. Bioorg Chem. 2018;80:86\u201393. https:\/\/doi.org\/10.1016\/J.BIOORG.2018.06.009.","journal-title":"Bioorg Chem"},{"key":"3624_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/J.EJMECH.2018.03.047","volume":"150","author":"MVP de Mello","year":"2018","unstructured":"de Mello MVP, Abrahim-Vieira B, de Domingos A, de Jesus TFS, de Sousa JB, Rodrigues ACC. A comprehensive review of chalcone derivatives as antileishmanial agents. Eur J Med Chem. 2018;150:920\u20139. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.03.047.","journal-title":"Eur J Med Chem"},{"key":"3624_CR7","doi-asserted-by":"publisher","first-page":"7903","DOI":"10.1007\/S11696-023-03060-3","volume":"77","author":"C Yamali","year":"2023","unstructured":"Yamali C, Sevin S, Nenni M, Tugrak Sakarya M, Uyar R, Aygul A, et al. Design, synthesis, and assessment of pharmacological properties of indole-based fluorinated chalcones and their benzenesulfonamide analogs. Chem Pap. 2023;77:7903\u201318. https:\/\/doi.org\/10.1007\/S11696-023-03060-3.","journal-title":"Chem Pap"},{"key":"3624_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S41061-024-00468-7","volume":"382","author":"R Mazumder","year":"2024","unstructured":"Mazumder R, Ichudaule, Ghosh A, Deb S, Ghosh R. Significance of Chalcone Scaffolds in Medicinal Chemistry. Top Curr Chem. 2024;382:1\u2013109. https:\/\/doi.org\/10.1007\/S41061-024-00468-7.","journal-title":"Top Curr Chem"},{"key":"3624_CR9","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/PH15101250","volume":"15","author":"G Rajendran","year":"2022","unstructured":"Rajendran G, Bhanu D, Aruchamy B, Ramani P, Pandurangan N, Bobba KN, et al. Chalcone: A Promising Bioactive Scaffold in Medicinal Chemistry. Pharmaceuticals. 2022;15:1250. https:\/\/doi.org\/10.3390\/PH15101250.","journal-title":"Pharmaceuticals"},{"key":"3624_CR10","doi-asserted-by":"publisher","first-page":"108903","DOI":"10.1016\/J.BIOORG.2025.108903","volume":"164","author":"N Barlak","year":"2025","unstructured":"Barlak N, Sanli F, Celik S, \u0130skender B, Anil DA, Gambacorta N, et al. Synthesis and evaluation of sulfonamide-chalcone hybrid compounds as inhibitors of VEGFR1\/VEGFR2-mediated angiogenesis. Bioorg Chem. 2025;164:108903. https:\/\/doi.org\/10.1016\/J.BIOORG.2025.108903.","journal-title":"Bioorg Chem"},{"key":"3624_CR11","doi-asserted-by":"publisher","first-page":"108694","DOI":"10.1016\/J.BIOORG.2025.108694","volume":"163","author":"MFA Mohamed","year":"2025","unstructured":"Mohamed MFA, Salem IM, Fouad A, Allam RM, Fadaly WAA, Nemr MTM, et al. Synthesis and apoptotic induction of sulfonamide-based chalcone hybrids as first-in-class dual histone deacetylase-carbonic anhydrase inhibitors with potential anti-tubulin activity. Bioorg Chem. 2025;163:108694. https:\/\/doi.org\/10.1016\/J.BIOORG.2025.108694.","journal-title":"Bioorg Chem"},{"key":"3624_CR12","doi-asserted-by":"publisher","first-page":"103527","DOI":"10.1016\/J.BIOORG.2019.103527","volume":"95","author":"A Rammohan","year":"2020","unstructured":"Rammohan A, Bhaskar BV, Venkateswarlu N, Gu W, Zyryanov GV. Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents. Bioorg Chem. 2020;95:103527. https:\/\/doi.org\/10.1016\/J.BIOORG.2019.103527.","journal-title":"Bioorg Chem"},{"key":"3624_CR13","doi-asserted-by":"publisher","unstructured":"Li Y, Sun B, Zhai J, Fu L, Zhang S, Zhang J, et al. Synthesis and antibacterial activity of four natural chalcones and their derivatives. Tetrahedron Lett. 2019;60. https:\/\/doi.org\/10.1016\/J.TETLET.2019.151165.","DOI":"10.1016\/J.TETLET.2019.151165"},{"key":"3624_CR14","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1039\/D3OB00792H","volume":"21","author":"MA Shalaby","year":"2023","unstructured":"Shalaby MA, Rizk SA, Fahim AM. Synthesis, reactions and application of chalcones: a systematic review. Org Biomol Chem. 2023;21:5317\u201346. https:\/\/doi.org\/10.1039\/D3OB00792H.","journal-title":"Org Biomol Chem"},{"key":"3624_CR15","doi-asserted-by":"publisher","first-page":"103057","DOI":"10.1016\/J.BIOORG.2019.103057","volume":"90","author":"HI Gul","year":"2019","unstructured":"Gul HI, Tugrak M, Gul M, Mazlumoglu S, Sakagami H, Gulcin I, et al. New phenolic Mannich bases with piperazines and their bioactivities. Bioorg Chem. 2019;90:103057. https:\/\/doi.org\/10.1016\/J.BIOORG.2019.103057.","journal-title":"Bioorg Chem"},{"key":"3624_CR16","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1080\/14756366.2019.1670657","volume":"34","author":"S Bilginer","year":"2019","unstructured":"Bilginer S, Gul HI, Erdal FS, Sakagami H, Levent S, Gulcin I, et al. Synthesis, cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones. J Enzyme Inhib Med Chem. 2019;34:1722. https:\/\/doi.org\/10.1080\/14756366.2019.1670657.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3624_CR17","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3109\/14756366.2012.700927","volume":"28","author":"S Bilginer","year":"2013","unstructured":"Bilginer S, Gul HI, Mete E, Das U, Sakagami H, Umemura N, et al. 1-(3-aminomethyl-4-hydroxyphenyl)-3-pyridinyl-2-propen-1-ones: a novel group of tumour-selective cytotoxins. J Enzyme Inhib Med Chem. 2013;28:974\u201380. https:\/\/doi.org\/10.3109\/14756366.2012.700927.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3624_CR18","doi-asserted-by":"publisher","unstructured":"Cruz EMS, Concato-Lopes VM, Detoni MB, Gon\u00e7alves-Lens MD, de Souza MC, Inoue FSR, et al. Chalcones as multitarget modulators in non-small cell lung cancer: mechanistic insights and therapeutic perspectives. Arch Toxicol. 2026;1\u201320. https:\/\/doi.org\/10.1007\/S00204-026-04501-0.","DOI":"10.1007\/S00204-026-04501-0"},{"key":"3624_CR19","doi-asserted-by":"publisher","first-page":"1746658","DOI":"10.3389\/FPHAR.2026.1746658","volume":"17","author":"M Valenzuela-Valderrama","year":"2026","unstructured":"Valenzuela-Valderrama M, Varas A, Rubilar M, Lorca M, Mella J, Espinosa-Bustos C, et al. 3D-QSAR study for the development of chalcone-based inhibitors targeting ovarian cancer cells with experimental validation. Front Pharmacol. 2026;17:1746658. https:\/\/doi.org\/10.3389\/FPHAR.2026.1746658.","journal-title":"Front Pharmacol"},{"key":"3624_CR20","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.2174\/1568026615666150915111741","volume":"16","author":"M Feng","year":"2016","unstructured":"Feng M, Tang B, Liang H, Jiang S. Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry. Curr Top Med Chem. 2016;16:1200\u201316. https:\/\/doi.org\/10.2174\/1568026615666150915111741.","journal-title":"Curr Top Med Chem"},{"key":"3624_CR21","doi-asserted-by":"publisher","unstructured":"Yamali C, Sakagami H, Satoh K, Bandow K, Uesawa Y, Bua S, et al. Investigation of carbonic anhydrase inhibitory effects and cytotoxicities of pyrazole-based hybrids carrying hydrazone and zinc-binding benzenesulfonamide pharmacophores. Bioorg Chem. 2022;127. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105969.","DOI":"10.1016\/j.bioorg.2022.105969"},{"key":"3624_CR22","doi-asserted-by":"publisher","unstructured":"Yamali C, Gul HI, Tugrak Sakarya M, Nurpelin Saglik B, Ece A, Demirel G, et al. Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies. Bioorg Chem. 2022;124. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105822.","DOI":"10.1016\/j.bioorg.2022.105822"},{"key":"3624_CR23","doi-asserted-by":"publisher","first-page":"e202403434","DOI":"10.1002\/CBDV.202403434","volume":"22","author":"AA Aslam","year":"2025","unstructured":"Aslam AA, Ahmed M, Mughram MHAL, Habib-ur-Rahman Mahmood M, Basheer S, Hussain R, et al. Sulfonamides as a Promising Scaffold in Drug Discovery: An Insightful Review on FDA-Approved Molecules, Synthesis Strategy, Medical Indication, and Their Binding Mode. Chem Biodivers. 2025;22:e202403434. https:\/\/doi.org\/10.1002\/CBDV.202403434.","journal-title":"Chem Biodivers"},{"key":"3624_CR24","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1039\/D1MD00058F","volume":"12","author":"R Ronchetti","year":"2021","unstructured":"Ronchetti R, Moroni G, Carotti A, Gioiello A, Camaioni E. Recent advances in urea- and thiourea-containing compounds: focus on innovative approaches in medicinal chemistry and organic synthesis. RSC Med Chem. 2021;12:1046\u201364. https:\/\/doi.org\/10.1039\/D1MD00058F.","journal-title":"RSC Med Chem"},{"key":"3624_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/J.EJMECH.2018.11.017","volume":"162","author":"C Zhao","year":"2019","unstructured":"Zhao C, Rakesh KP, Ravidar L, Fang WY, Qin HL. Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review. Eur J Med Chem. 2019;162:679\u2013734. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.11.017.","journal-title":"Eur J Med Chem"},{"key":"3624_CR26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2174\/1385272822666180122153839","volume":"22","author":"FA Khan","year":"2018","unstructured":"Khan FA, Mushtaq S, Naz S, Farooq U, Zaidi A, Bukhari SM, et al. Sulfonamides as Potential Bioactive Scaffolds. Curr Org Chem. 2018;22:818\u201330. https:\/\/doi.org\/10.2174\/1385272822666180122153839.","journal-title":"Curr Org Chem"},{"key":"3624_CR27","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/CBDD.13043","volume":"90","author":"A Ammazzalorso","year":"2017","unstructured":"Ammazzalorso A, De Filippis B, Giampietro L, Amoroso R. N-acylsulfonamides: Synthetic routes and biological potential in medicinal chemistry. Chem Biol Drug Des. 2017;90:1094\u2013105. https:\/\/doi.org\/10.1111\/CBDD.13043.","journal-title":"Chem Biol Drug Des"},{"key":"3624_CR28","doi-asserted-by":"publisher","first-page":"e70180","DOI":"10.1002\/ARDP.70180","volume":"359","author":"S Zerbib","year":"2026","unstructured":"Zerbib S, Cruz-Martins N, Bouissane L. Exploring Sulfonamides: Biological Activities and Structure\u2013Activity Relationships. Arch Pharm (Weinheim). 2026;359:e70180. https:\/\/doi.org\/10.1002\/ARDP.70180.","journal-title":"Arch Pharm (Weinheim)"},{"key":"3624_CR29","doi-asserted-by":"publisher","first-page":"2000230","DOI":"10.1002\/ARDP.202000230","volume":"354","author":"M Tugrak","year":"2021","unstructured":"Tugrak M, Gul HI, Demir Y, Gulcin I. Synthesis of benzamide derivatives with thiourea-substituted benzenesulfonamides as carbonic anhydrase inhibitors. Arch Pharm (Weinheim). 2021;354:2000230. https:\/\/doi.org\/10.1002\/ARDP.202000230.","journal-title":"Arch Pharm (Weinheim)"},{"key":"3624_CR30","doi-asserted-by":"publisher","first-page":"107409","DOI":"10.1016\/J.BIOORG.2024.107409","volume":"147","author":"KA Elsayad","year":"2024","unstructured":"Elsayad KA, Elmasry GF, Mahmoud ST, Awadallah FM. Sulfonamides as anticancer agents: A brief review on sulfonamide derivatives as inhibitors of various proteins overexpressed in cancer. Bioorg Chem. 2024;147:107409. https:\/\/doi.org\/10.1016\/J.BIOORG.2024.107409.","journal-title":"Bioorg Chem"},{"key":"3624_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/J.BIOORG.2018.01.021","volume":"77","author":"HI Gul","year":"2018","unstructured":"Gul HI, Yamali C, Sakagami H, Angeli A, Leitans J, Kazaks A, et al. New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors. Bioorg Chem. 2018;77:411\u20139. https:\/\/doi.org\/10.1016\/J.BIOORG.2018.01.021.","journal-title":"Bioorg Chem"},{"key":"3624_CR32","doi-asserted-by":"publisher","first-page":"103222","DOI":"10.1016\/J.BIOORG.2019.103222","volume":"92","author":"C Yamali","year":"2019","unstructured":"Yamali C, Gul HI, Ece A, Bua S, Angeli A, Sakagami H, et al. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors. Bioorg Chem. 2019;92:103222. https:\/\/doi.org\/10.1016\/J.BIOORG.2019.103222.","journal-title":"Bioorg Chem"},{"key":"3624_CR33","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/J.BIOORG.2018.03.027","volume":"78","author":"HI Gul","year":"2018","unstructured":"Gul HI, Yamali C, Bulbuller M, Kirmizibayrak PB, Gul M, Angeli A, et al. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes. Bioorg Chem. 2018;78:290\u20137. https:\/\/doi.org\/10.1016\/J.BIOORG.2018.03.027.","journal-title":"Bioorg Chem"},{"key":"3624_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/14756366.2016.1243536","volume":"32","author":"HI Gul","year":"2017","unstructured":"Gul HI, Mete E, Eren SE, Sakagami H, Yamali C, Supuran CT. Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides. J Enzyme Inhib Med Chem. 2017;32:169\u201375. https:\/\/doi.org\/10.1080\/14756366.2016.1243536.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3624_CR35","doi-asserted-by":"publisher","first-page":"113351","DOI":"10.1016\/J.EJMECH.2021.113351","volume":"217","author":"C Yamali","year":"2021","unstructured":"Yamali C, Sakagami H, Uesawa Y, Kurosaki K, Satoh K, Masuda Y, et al. Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides. Eur J Med Chem. 2021;217:113351. https:\/\/doi.org\/10.1016\/J.EJMECH.2021.113351.","journal-title":"Eur J Med Chem"},{"key":"3624_CR36","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/0145-2126(86)90331-0","volume":"10","author":"PA Cassileth","year":"1986","unstructured":"Cassileth PA, Gale RP. Amsacrine: a review. Leuk Res. 1986;10:1257\u201365. https:\/\/doi.org\/10.1016\/0145-2126(86)90331-0.","journal-title":"Leuk Res"},{"key":"3624_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/NRD.2016.253","volume":"16","author":"A Ashkenazi","year":"2017","unstructured":"Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov. 2017;16:273\u201384. https:\/\/doi.org\/10.1038\/NRD.2016.253.","journal-title":"Nat Rev Drug Discov"},{"key":"3624_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1021\/ACS.JMEDCHEM.5B01888","volume":"60","author":"JL Yap","year":"2017","unstructured":"Yap JL, Chen L, Lanning ME, Fletcher S. Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules. J Med Chem. 2017;60:821\u201338. https:\/\/doi.org\/10.1021\/ACS.JMEDCHEM.5B01888.","journal-title":"J Med Chem"},{"key":"3624_CR39","doi-asserted-by":"publisher","unstructured":"Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7. https:\/\/doi.org\/10.1038\/SREP42717.","DOI":"10.1038\/SREP42717"},{"key":"3624_CR40","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1007\/S11094-024-03076-3","volume":"57","author":"C Yamali","year":"2024","unstructured":"Yamali C, Nenni M, Sakarya MT, Sakagami H, Gul HI. Biological Activities and Drug-Likeness Properties of Phenol-Based Heterocyclic Compounds. Pharm Chem J. 2024;57:1754\u201360. https:\/\/doi.org\/10.1007\/S11094-024-03076-3.","journal-title":"Pharm Chem J"},{"key":"3624_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/10426500307933","volume":"178","author":"OS Moustafa","year":"2003","unstructured":"Moustafa OS, Ahmad RA. Synthesis and Antimicrobial Activity of Some New Cyanopyridines, Isoxazoles, Pyrazoles, and Pyrimidines Bearing Sulfonamide Moiety. Phosphorus Sulfur Silicon Relat Elem. 2003;178:475\u201384. https:\/\/doi.org\/10.1080\/10426500307933.","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"3624_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3998\/ARK.5550190.P009.488","volume":"2016","author":"NR Agrawal","year":"2016","unstructured":"Agrawal NR, Bahekar SP, Agrawal AR, Sarode PB, Chandak HS. Cascade Michael-Aldol reaction: Efficient annulation of sulfonamide chalcones into novel cyclohexenones under solvent-free conditions. Arkivoc. 2016;2016:227\u201345. https:\/\/doi.org\/10.3998\/ARK.5550190.P009.488.","journal-title":"Arkivoc"},{"key":"3624_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/J.EJMECH.2016.08.042","volume":"124","author":"SP Bahekar","year":"2016","unstructured":"Bahekar SP, Hande SV, Agrawal NR, Chandak HS, Bhoj PS, Goswami K, et al. Sulfonamide chalcones: Synthesis and in vitro exploration for therapeutic potential against Brugia malayi. Eur J Med Chem. 2016;124:262\u20139. https:\/\/doi.org\/10.1016\/J.EJMECH.2016.08.042.","journal-title":"Eur J Med Chem"},{"key":"3624_CR44","doi-asserted-by":"publisher","first-page":"818","DOI":"10.3109\/14756366.2015.1070263","volume":"31","author":"M Tugrak","year":"2016","unstructured":"Tugrak M, Yamali C, Sakagami H, Gul HI. Synthesis of mono Mannich bases of 2-(4-hydroxybenzylidene)-2,3-dihydroinden-1-one and evaluation of their cytotoxicities. J Enzyme Inhib Med Chem. 2016;31:818\u201323. https:\/\/doi.org\/10.3109\/14756366.2015.1070263.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3624_CR45","first-page":"5299","volume":"35","author":"Y Uesawa","year":"2015","unstructured":"Uesawa Y, Sakagami H, Ishihara M, Kagaya H, Kanamoto T, Terakubo S, et al. Quantitative Structure\u2013Cytotoxicity Relationship of 3-Styryl-2H-chromenes. Anticancer Res. 2015;35:5299\u2013307.","journal-title":"Anticancer Res"},{"key":"3624_CR46","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/S00044-017-1911-0","volume":"26","author":"C Yamali","year":"2017","unstructured":"Yamali C, Ozgun DO, Inci Gul H, Sakagami H, Kazaz C, Okudaira N. Synthesis and structure elucidation of 1-(2,5\/3,5-difluorophenyl)-3-(2,3\/2,4\/2,5\/3,4-dimethoxyphenyl)-2-propen-1-ones as anticancer agents. Med Chem Res. 2017;26:2015\u201323. https:\/\/doi.org\/10.1007\/S00044-017-1911-0.","journal-title":"Med Chem Res"},{"key":"3624_CR47","doi-asserted-by":"publisher","first-page":"763","DOI":"10.21873\/anticanres.12282","volume":"38","author":"H Sakagami","year":"2018","unstructured":"Sakagami H, Okudaira N, Uesawa Y, Takao K, Kagaya H, Sugita Y. Quantitative Structure\u2013Cytotoxicity Relationship of 2-Azolylchromones. Anticancer Res. 2018;38:763\u201370. https:\/\/doi.org\/10.21873\/anticanres.12282.","journal-title":"Anticancer Res"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03624-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03624-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:23:14Z","timestamp":1790666594000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03624-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":47,"alternative-id":["3624"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03624-4","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"26 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}